Dr. Roofeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
125 Paterson Ave
New Brunswick, NJ 08901Phone+1 732-235-7217- Is this information wrong?
Education & Training
- University of Michigan Health SystemFellowship, Rheumatology, 2017 - 2019
- Sidney Kimmel Medical College at Thomas Jefferson University/Christiana Care Health ServicesResidency, Internal Medicine/Pediatrics, 2013 - 2017
- SUNY Upstate Medical UniversityClass of 2013
Certifications & Licensure
- NJ State Medical License 2023 - 2025
- MI State Medical License 2017 - 2023
- PA State Medical License 2017 - 2018
- DE State Medical License 2013 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 6 citationsRisk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort.Ahmad Ramahi, Alain Lescoat, David Roofeh, Vivek Nagaraja, Rajaie Namas, Suiyuan Huang, John Varga, David O'Dwyer, Bonnie Wang, Kevin Flaherty, Ella Kazerooni, Dinesh ...> ;Rheumatology. 2023 Jul 5
- 7 citationsSystemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.David Roofeh, Kevin K Brown, Ella A Kazerooni, Donald Tashkin, Shervin Assassi, Fernando Martinez, Athol U Wells, Ganesh Raghu, Christopher P Denton, Lorinda Chung, An...> ;Rheumatology. 2023 May 2
- Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review.Alain Lescoat, Robert D Sandler, François Zimmermann, David Roofeh, Michael Hughes, John D Pauling, Susan L Murphy, Yen T Chen, Whitney Townsend, Maya H Buch, Dinesh K...> ;Rheumatology. 2022 Aug 3
- Join now to see all
Press Mentions
- Tocilizumab Effective for Early SSc-Associated Interstitial Lung DiseaseSeptember 22nd, 2021
- Tocilizumab May Improve Lung Function in Early Systemic SclerosisFebruary 17th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: